CNC logo

Centene Corporation (CNC)

$63.74

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CNC

Market cap

$31.47B

EPS

-13.05

P/E ratio

--

Price to sales

0.13

Dividend yield

--

Beta

1.076693

Price on CNC

Previous close

$65.89

Today's open

$63.95

Day's range

$62.86 - $64.90

52 week range

$25.08 - $69.36

Profile about CNC

CEO

Sarah M. London

Employees

60500

Headquarters

St. Louis, MO

Exchange

New York Stock Exchange

Shares outstanding

493797000

Issue type

Common Stock

CNC industries and sectors

Healthcare

Medical Service Plans

News on CNC

Centene (CNC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Beyond analysts' top-and-bottom-line estimates for Centene (CNC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

news source

Zacks Investment Research • a day ago

news preview

Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates

CNC reports Q2 results July 28 as investors weigh improving profitability against membership declines and revenue pressure ahead of earnings.

news source

Zacks Investment Research • Jul 22, 2026

news preview

UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost

The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.

news source

Barrons • Jul 16, 2026

news preview

Centene Stock Soars 66% YTD: Should Investors Chase the Rally?

Centene Corporation CNC, one of the largest managed healthcare providers in the United States, has staged an impressive comeback in 2026. The stock has surged 66% year to date, far ahead of the industry's  28.5% gain.

news source

Zacks Investment Research • Jul 14, 2026

news preview

CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

ST. LOUIS, July 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 second quarter financial results at approximately 6:00 a.m. ET on Tuesday, July 28, 2026, and host a conference call at 8:30 a.m.

news source

PRNewsWire • Jul 10, 2026

news preview

Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?

Centene secures a four-year Illinois Medicaid contract renewal, preserving a key membership base and reinforcing long-term revenue stability.

news source

Zacks Investment Research • Jul 10, 2026

news preview

CENTENE SUBSIDIARY MERIDIAN HEALTH PLAN OF ILLINOIS AWARDED ILLINOIS MEDICAID CONTRACT

ST. LOUIS, July 9, 2026 /PRNewswire/ -- Centene Corporation (Centene) (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Illinois subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing services for the HealthChoice Illinois Medicaid managed care program. The four-year contract is expected to begin January 1, 2027, through 2030.

news source

PRNewsWire • Jul 9, 2026

news preview

Can Centene's Operational Execution Keep Margin Recovery on Track?

Centene Corporation's CNC margin recovery story appears to be shifting from strategy to execution. The company has rolled out several initiatives to better manage medical costs, modernize and standardize processes, and strengthen payment integrity.

news source

Zacks Investment Research • Jul 9, 2026

news preview

Can Centene's Fraud Prevention Strategy Support Margin Recovery?

CNC expands AI-driven fraud prevention and payment integrity to improve Medicaid margins, boost cost controls and support long-term earnings growth.

news source

Zacks Investment Research • Jul 6, 2026

news preview

Centene Proved Bears Wrong

Centene has surged over 150% since my upgrade, driven by robust Q1 results and margin improvements. Medicaid and Medicare Advantage performance exceeded expectations, with management reaffirming a 2027 breakeven target for Medicare Advantage. CNC's balance sheet has strengthened, with reduced debt and $1.8 billion remaining for share buybacks, supporting further capital allocation flexibility.

news source

Seeking Alpha • Jul 6, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Centene Corporation

Open an M1 investment account to buy and sell Centene Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CNC on M1